Crown Bioscience Inc.
Crown Bioscience to Showcase Scientific Expertise in Preclinical Evaluation of Investigational Cancer Compounds
CrownBio's scientists will present 13 scientific posters describing their latest research efforts, including generation of novel models for combinatory chemotherapy and immunotherapy studies, creation of 3D screening panels for improved efficacy assessments, demonstration of a checkpoint immunotherapy modulating intestinal microbiota, among other innovative developments in cancer therapeutics and preclinical pharmacology evaluation.
On Saturday October 28th , Crown Bioscience's Dr. Henry Li will deliver an oral presentation entitled, "Transcriptomic analysis of patient-derived xenografts reveals heterogeneity in human and mouse stroma/immune compartments" , as part of the conference's Challenges and Opportunities of Genomic Based Clinical Trials Plenary Session.
"I am excited to share Crown Bioscience's cutting-edge research with colleagues at AACR- NCI-EORTC," said Dr. Henry Li, Crown Bioscience's Vice President of Translational Oncology. "The data presented will exhibit the utility of our clinically relevant PDX models to identify critical biomarkers and improve preclinical evaluation of cancer therapies."
"Crown Bioscience is honored to play a leading role in presenting opportunities for scientific advancements at AACR-NCI-EORTC," said Laurie Heilmann, Chief Business Officer. "The work of our dedicated scientific team exemplifies Crown Bioscience's commitment to helping researchers solve global health challenges through continued innovation of our scientific translational platform."
Delegates can request copies of the posters and learn more about Crown Bioscience's scientific translational platform at booth 601.
About Crown Bioscience Inc.
Crown Bioscience is a global drug discovery and development solutions company providing translational platforms to advance oncology, inflammation and metabolic disease research. With an extensive portfolio of relevant models and predictive tools, Crown Bioscience enables clients to deliver superior clinical candidates.
Crown Bioscience Inc.
Information om Globenewswire
Følg pressemeddelelser fra Globenewswire
Skriv dig op her og modtag pressemeddelelser på mail. Indtast din mail, klik på abonner og følg instruktionerne i den udsendte mail.
Flere pressemeddelelser fra Globenewswire
Magna International Inc.19.7.2018 21:36 | pressemeddelelse
Second Quarter 2018 Results Conference Call
Crown Bioscience Inc.19.7.2018 15:05 | pressemeddelelse
CrownBio Supports Excellence in Translational Research with Grant Award that Funds Innovative PDX Model Development in Immuno-Oncology
ForgeRock, Inc.19.7.2018 10:03 | pressemeddelelse
ForgeRock Opens Up Open Banking
David Crosby18.7.2018 18:06 | pressemeddelelse
David Crosby Announces Intent to License His Name to the Cannabis Industry
Seaborn Networks18.7.2018 17:02 | pressemeddelelse
Telecom Argentina's landing station and backhaul are selected for ARBR submarine cable system between Argentina & Brazil
Mitratech18.7.2018 15:04 | pressemeddelelse
Salim Ismail Announced as Keynote Speaker at Mitratech's Interact 2018 Conference
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum